A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Niraparib in Combination With Pembrolizumab in Patients With Triple-negative Breast Cancer or Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
LCL161 Plus Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers
- Status
- UNKNOWN
- Phase
- N/A
A Study of LY2880070 in Participants With Advanced or Metastatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Women With Folate Receptor (FR) Alpha Positive Advanced Epithelial Ovarian Cancer (EOC), Primary Peritoneal or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of MGD009 in B7-H3-expressing Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Advanced Methods for Cancer Detection by Vaginal Screening
- Status
- COMPLETED
- Phase
- NA
Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours.
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of LXH254 in Patients With Advanced Solid Tumors Haboring MAPK Pathway Alterations
- Status
- TERMINATED
- Phase
- PHASE1
Writing About Experiences With Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
- Status
- COMPLETED
- Phase
- NA
MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200)
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
- Status
- TERMINATED
- Phase
- PHASE1
PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2